Senior insider sale
EVP, Europe Commercial at TEVA PHARMACEUTICAL INDUSTRIES LTD — senior position signals high conviction
$11.02M
353.09K shares
What this filing means
DANIELL RICHARD plans to sell 353.09K shares of TEVA PHARMACEUTICAL INDUSTRIES LTD valued at approximately $11.02M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/5/2026ACC: 0001973379-26-000086
Officer· EVP, Europe Commercial
Since Mar 2026
353.09K
Shares to sell
$11.02M
Approx. market value
17.30K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
RESTRICTED SHARE AWARD EM
COMPENSATION
3/5/2025
17.30KTotal acquired17.30K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/5/2025 | RESTRICTED SHARE AWARD EM COMPENSATION | 17.30K | — |
| Total | 17.30K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
91.34K
Market value
$2.98M
3/4/2026
—Completed
Units to sell
128.99K
Market value
$4.17M
3/3/2026
—Completed
Units to sell
115.47K
Market value
$3.31M
12/9/2025
Planned — Approximate Date
NYSEPlanned
Units to sell
17.30K
Market value
$547.7K
3/5/2026
Total
Units
353.09K
Value
$11.02M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/4/2026 | 91.34K | $2.98M | — | Completed |
3/3/2026 | 128.99K | $4.17M | — | Completed |
12/9/2025 | 115.47K | $3.31M | — | Completed |
| Planned — Approximate Date | ||||
3/5/2026 | 17.30K | $547.7K | NYSE | Planned |
| Total | 353.09K | $11.02M | ||